A Subpopulation of the K562 Cells Are Killed by Curcumin Treatment after G2/M Arrest and Mitotic Catastrophe

Curcumin is extensively investigated as a good chemo-preventive agent in the development of many cancers and particularly in leukemia, including treatment of chronic myelogenous leukemia and it has been proposed as an adjuvant for leukemia therapies. Human chronic myeloid leukemia cells (K562), were...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez-Castillo, Macario, Bonilla-Moreno, Raul, Aleman-Lazarini, Leticia, Meraz-Rios, Marco Antonio, Orozco, Lorena, Cedillo-Barron, Leticia, Cordova, Emilio J., Villegas-Sepulveda, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104431/
https://www.ncbi.nlm.nih.gov/pubmed/27832139
http://dx.doi.org/10.1371/journal.pone.0165971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104431/
https://www.ncbi.nlm.nih.gov/pubmed/27832139
http://dx.doi.org/10.1371/journal.pone.0165971

Ejemplares similares